Lifeward (LFWD) FCF Margin Growth (3y) (2018 - 2026)
Lifeward (LFWD) FCF Margin Growth (3y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.81 Bn | 175.52 Bn | 6.27 Bn | 38.00 |
| 2 | Stryker | 128.98 Bn | 126.10 Bn | 3.81 Bn | 30.00 |
| 3 | Medtronic | 108.67 Bn | 99.45 Bn | 6.41 Bn | -310.00 |
| 4 | Boston Scientific | 68.36 Bn | 66.91 Bn | 3.61 Bn | 96.00 |
| 5 | Edwards Lifesciences | 47.70 Bn | 44.03 Bn | 1.29 Bn | -2,196.00 |
| 6 | Dexcom | 28.67 Bn | 27.55 Bn | 750.30 Mn | 2,679.00 |
| 7 | GE HealthCare Technologies | 28.55 Bn | 26.27 Bn | 1.98 Bn | -472.00 |
| 8 | Smith & Nephew | 26.97 Bn | 26.40 Bn | - | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.33 Bn | 2.07 Bn | -20.00 |
| 10 | Lifeward | 11.10 Mn | -322,423.81 | 1.34 Mn | 33,177.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 33,177.00 |
| Dec 31, 2025 | 10,997.00 |
| Sep 30, 2025 | 45,714.00 |
| Jun 30, 2025 | 16,639.00 |
| Mar 31, 2025 | 54,272.00 |
| Dec 31, 2024 | 15,553.00 |
| Sep 30, 2024 | 5,807.00 |
| Jun 30, 2024 | 13,693.00 |
| Mar 31, 2024 | 9,655.00 |
| Dec 31, 2023 | 13,552.00 |
| Sep 30, 2023 | 18,644.00 |
| Jun 30, 2023 | -7,050.00 |
| Mar 31, 2023 | 14,692.00 |
| Dec 31, 2022 | 12,559.00 |
| Sep 30, 2022 | -25,518.00 |
| Jun 30, 2022 | 18,759.00 |
| Mar 31, 2022 | -38,293.00 |
| Dec 31, 2021 | -4,284.00 |
| Sep 30, 2021 | 6,162.00 |
| Jun 30, 2021 | 768.00 |